Nicole Erin Kinsey White

Array ( [id] => 4771834 [patent_doc_number] => 20080057492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Interacting site for gp41 on gp120 of hiv-1' [patent_app_type] => utility [patent_app_number] => 10/513884 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17568 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057492.pdf [firstpage_image] =>[orig_patent_app_number] => 10513884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807652 [patent_doc_number] => 20060094006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Immunotherapy regimens in hiv-infected patients' [patent_app_type] => utility [patent_app_number] => 10/513257 [patent_app_country] => US [patent_app_date] => 2003-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14301 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094006.pdf [firstpage_image] =>[orig_patent_app_number] => 10513257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7261281 [patent_doc_number] => 20040241140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Expression vectors able to elicit improved immune response and methods of using same' [patent_app_type] => new [patent_app_number] => 10/415431 [patent_app_country] => US [patent_app_date] => 2003-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16182 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241140.pdf [firstpage_image] =>[orig_patent_app_number] => 10415431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729665 [patent_doc_number] => 20030185855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'HSV viral vector' [patent_app_type] => new [patent_app_number] => 10/422547 [patent_app_country] => US [patent_app_date] => 2003-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5873 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185855.pdf [firstpage_image] =>[orig_patent_app_number] => 10422547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701473 [patent_doc_number] => 20030224353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Antisense antiviral agent and method for treating ssRNA viral infection' [patent_app_type] => new [patent_app_number] => 10/422671 [patent_app_country] => US [patent_app_date] => 2003-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15024 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224353.pdf [firstpage_image] =>[orig_patent_app_number] => 10422671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6663661 [patent_doc_number] => 20030202987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Particles of HCV envelope proteins: use for vaccination' [patent_app_type] => new [patent_app_number] => 10/414219 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 17651 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20030202987.pdf [firstpage_image] =>[orig_patent_app_number] => 10414219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739697 [patent_doc_number] => 20030157066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Compositions comprising viruses and methods for concentrating virus preparations' [patent_app_type] => new [patent_app_number] => 10/365632 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7906 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157066.pdf [firstpage_image] =>[orig_patent_app_number] => 10365632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4302 [patent_doc_number] => 07811812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis' [patent_app_type] => utility [patent_app_number] => 10/391441 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 68 [patent_no_of_words] => 65681 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/811/07811812.pdf [firstpage_image] =>[orig_patent_app_number] => 10391441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 456977 [patent_doc_number] => 07244814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'Variant Tat proteins and methods for use thereof' [patent_app_type] => utility [patent_app_number] => 10/505265 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2965 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244814.pdf [firstpage_image] =>[orig_patent_app_number] => 10505265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154264 [patent_doc_number] => 20070037147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Endogenous retrovirus polypeptides linked to oncogenic transformation' [patent_app_type] => utility [patent_app_number] => 10/497786 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 28461 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037147.pdf [firstpage_image] =>[orig_patent_app_number] => 10497786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5888582 [patent_doc_number] => 20060275747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Endogenous retrovirus up-regulated in prostate cancer' [patent_app_type] => utility [patent_app_number] => 10/498033 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 38630 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275747.pdf [firstpage_image] =>[orig_patent_app_number] => 10498033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251622 [patent_doc_number] => 20040259075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes' [patent_app_type] => new [patent_app_number] => 10/492729 [patent_app_country] => US [patent_app_date] => 2004-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14898 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259075.pdf [firstpage_image] =>[orig_patent_app_number] => 10492729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693965 [patent_doc_number] => 20070015721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Hiv-gag codon-optimised dna vaccines' [patent_app_type] => utility [patent_app_number] => 10/490011 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 14234 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015721.pdf [firstpage_image] =>[orig_patent_app_number] => 10490011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860585 [patent_doc_number] => 20030091593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles' [patent_app_type] => new [patent_app_number] => 10/243739 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 37010 [patent_no_of_claims] => 194 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091593.pdf [firstpage_image] =>[orig_patent_app_number] => 10243739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011604 [patent_doc_number] => 20050065320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Mutated env gene, mutated env glycoprotein and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/487094 [patent_app_country] => US [patent_app_date] => 2002-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12370 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065320.pdf [firstpage_image] =>[orig_patent_app_number] => 10487094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706282 [patent_doc_number] => 20030153016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'PSCA: prostate stem cell antigen' [patent_app_type] => new [patent_app_number] => 10/225779 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 46052 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153016.pdf [firstpage_image] =>[orig_patent_app_number] => 10225779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 84077 [patent_doc_number] => 07741453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Long lasting fusion peptide inhibitors for HIV infection' [patent_app_type] => utility [patent_app_number] => 10/478811 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8217 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741453.pdf [firstpage_image] =>[orig_patent_app_number] => 10478811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694961 [patent_doc_number] => 20060155108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Multiple branch peptide construction' [patent_app_type] => utility [patent_app_number] => 10/126915 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3243 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20060155108.pdf [firstpage_image] =>[orig_patent_app_number] => 10126915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5742820 [patent_doc_number] => 20060088545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Use of inhibitors of the protease of the human immunodeficiency virus (hiv) to block cell migration and/or invasion, tissue infiltration and oedema for the therary of diseases associated therewith' [patent_app_type] => utility [patent_app_number] => 10/549958 [patent_app_country] => US [patent_app_date] => 2002-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 19720 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088545.pdf [firstpage_image] =>[orig_patent_app_number] => 10549958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421944 [patent_doc_number] => 08278432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'HBV drug resistance methods' [patent_app_type] => utility [patent_app_number] => 10/509094 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27038 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10509094 [rel_patent_id] =>[rel_patent_doc_number] =>)